Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis opticaMichael Levy, Maureen A Mealy
Immunotargets and Therapy|August 27, 2021
B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20Michael Levy, Maureen A Mealy
Journal of the Neurological Sciences|January 30, 2017
TNF-alpha inhibitor associated myelopathies: A neurological complication in patients with rheumatologic disordersPaula Barreras, Maureen A Mealy, Carlos A Pardo
Current Treatment Options in Neurology|December 27, 2015
Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and SymptomaticRemi A Kessler, Maureen A Mealy, Michael Levy
Neurology(R) Neuroimmunology & Neuroinflammation|August 11, 2016
Early indicators of relapses vs pseudorelapses in neuromyelitis optica spectrum disorderRemi A Kessler, Maureen A Mealy, Michael Levy
Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses|May 20, 2019
Review of Treatment for Central Spinal Neuropathic Pain and Its Effect on Quality of Life: Implications for Neuromyelitis Optica Spectrum DisorderMaureen A Mealy, Sharon L Kozachik, Michael Levy
International Journal of MS Care|June 14, 2019
Assessment of Patients with Neuromyelitis Optica Spectrum Disorder Using the EQ-5DMaureen A Mealy, Audra Boscoe, Jaime Caro, et al.
Clinical & Experimental Neuroimmunology|February 3, 2016
Bevacizumab is safe in acute relapses of neuromyelitis opticaMaureen A Mealy, Kyong Shin, Gareth John, et al.
Pageof 5